Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Plos One|March 9, 2019
Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled studyDominik Berzaczy, Alexander R Haug, Markus Raderer, et al.
Molecular Imaging and Biology|August 1, 2019
Whole-Body [18F]FDG-PET/MRI vs. [18F]FDG-PET/CT in Malignant MelanomaDominik Berzaczy, Barbara Fueger, Christoph Hoeller, et al.
Wiener Klinische Wochenschrift|May 21, 2020
Particular findings on lung CT in patients undergoing immunotherapy for bronchogenic carcinomaLucian Beer, Maximilian Hochmair, Daria Kifjak, et al.
Clinical Nuclear Medicine|July 7, 2017
Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 PatientsDominik Berzaczy, Chiara Giraudo, Alexander R Haug, et al.
The British Journal of Ophthalmology|January 16, 2016
Combined positron emission tomography/computed tomography (PET/CT) for imaging of orbital tumours and tumours extending into the orbitAnnemarie Klingenstein, Gerd-Ullrich Mueller-Lisse, Alexander R Haug, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 7, 2015
Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolizationHarun Ilhan, Anna Goritschan, Phillip Paprottka, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 24, 2017
Efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysisAmir Sabet, Alexander R Haug, Collin Eiden, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2024
Multicenter PET image harmonization using generative adversarial networksDavid Haberl, Clemens P Spielvogel, Zewen Jiang, et al.
Pageof 9